A Phase 1 Study to Assess the Effect of Hepatic Impairment on the Pharmacokinetics of Repotrectinib in Advanced Cancer Patients

Clinical trial NCT05828277 · WITHDRAWN

Trial details

NCT number: NCT05828277
Sponsor: Turning Point Therapeutics, Inc.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Solid Tumor Metastatic Solid Tumor

Start date: 2022-07-28
Primary completion: 2025-08-31
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.